Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

7 ArticlesRanbaxy

1 / 1

Daiichi Loses 20% on Selling Its Stake in Sun Pharma; Larger Questions on Market Liquidity Too

Sun Pharma has fallen 10% to 940 as Daiichi prepares to sell its stake of 214 million shares, on the stock exchanges. Daiichi acquired Ranbaxy at the price of ...

Sun-Baxy Deal Dinged For Insider Trading

The SunPharma-Ranbaxy deal has hit a little snag. The Andhra Pradesh High Court has temporarily stalled the merger, asking SEBI and stock exchanges not to ...

Sun Pharma and Ranbaxy to Merge, Create Giant Pharma Co

The big news of the week was about a mega-merger of two of India’s largest pharma companies, Sun Pharma and Ranbaxy. ...

Nifty Bids Adieu to JP and Ranbaxy, Adds TechM and United Spirits

The NSE has changed the constituents of the Nifty from March 28, 2014. JP Associates is being replaced with Tech Mahindra Ranbaxy is being replaced with United ...

The Can of Worms at Ranbaxy

Fortune magazine has a long and detailed story about Ranbaxy and the reason for its $500 million settlement with the FDA. But in Gurgaon, as Thakur’s ...

Ranbaxy: A very short term buy?

Ranbaxy has this open offer that’s ending on Thursday. Tomorrow is a holiday, and delivery is T+2, so the last trade for the open offer would have been ...

Ranbaxy Open Offer: Download Letter

For all those who have not received the Letter of Offer for the Ranbaxy Open offer at Rs. 737; you can download the letter of offer here. Process: First go ...